Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Secondary Amines. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel metal-free catalyst technology enabling high-purity chiral secondary amines with significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN113583992A reveals a novel RsRedAm enzyme for efficient secondary amine synthesis, offering mild conditions and high selectivity for pharmaceutical intermediates.
Patent CN103864624A reveals a solvent-free, metal-free N-alkylation method. Discover cost-effective manufacturing and high-purity supply chain solutions for pharmaceutical intermediates.
Novel boron-catalyzed hydroamination method offers high yield and mild conditions for pharmaceutical intermediates manufacturing ensuring supply chain reliability.
Patent CN107382741B details a high-yield B(C6F5)3 catalyzed hydroamination. Offers cost-effective, scalable routes for pharmaceutical intermediates with minimal impurities.